Mastering the Integration of Immunotherapy in Resectable NSCLC Multidisciplinary Perspectives on the State of the Science, Key Questions, and Practical Considerations for Optimal Use of Immunotherapy Approaches in Real-World Practice
- Provider:PVI, PeerView Institute for Medical Education
- Activity Link: https://www.peerview.com/JUZ
- Start Date: 2025-01-26 06:00:00
- End Date: 2025-01-26 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours - MOC Credit Details: ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM) - Commercial Support: Source: AstraZeneca (Any division) - Amount: 6072.0 - Is Kind Support: False Source: Bristol-Myers Squibb Company - Amount: 37949.0 - Is Kind Support: False Source: Merck (Any division) - Amount: 25673.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Clinical Pathology, Medical Oncology, Pulmonary Disease, Pulmonary, Mediastinum
Subscribe
Login
0 Comments
Oldest